4.4 Article

Synergistic and antagonistic interactions between tetrodotoxin and mu-conotoxin in blocking voltage-gated sodium channels

Journal

CHANNELS
Volume 3, Issue 1, Pages 32-38

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/chan.3.1.7500

Keywords

conotoxin; contratoxin; Na(V)1.2; oocyte; sodium channel; Site 1; syntoxin; tetrodotoxin; voltage clamp

Funding

  1. National Institutes of Health [GM 48677, NS055845]
  2. Heart and Stroke Foundation of Alberta, Northwest Territories and Nunavut
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055845] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Tetrodotoxin (TTX) is the quintessential ligand of voltage-gated sodium channels (Na(V)s). Like TTX, mu-conotoxin peptides are pore blockers, and both toxins have helped to define the properties of neurotoxin receptor Site 1 of NaVs. Here, we report unexpected results showing that the recently discovered mu-conotoxin KIIIA and TTX can simultaneously bind to Site 1 and act in concert. Results with saturating concentrations of peptide applied to voltage-clamped Xenopus oocytes expressing brain Na(V)1.2, and single-channel recordings from brain channels in lipid bilayers, show that KIIIA or its analog, KIIIA[K7A], block partially, with a residual current that can be completely blocked by TTX. In addition, the kinetics of block by TTX and peptide are each affected by the prior presence of the other toxin. For example, bound peptide slows subsequent binding of TTX (an antagonistic interaction) and slows TTX dissociation when both toxins are bound (a synergistic effect on block). The overall functional consequence resulting from the combined action of the toxins depends on the quantitative balance between these opposing actions. The results lead us to postulate that in the bi-liganded Na-V complex, TTX is bound between the peptide and the selectivity filter. These observations refine our view of Site 1 and open new possibilities in Na-V pharmacology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels

Jeffrey R. McArthur, Rocio K. Finol-Urdaneta, David J. Adams

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Article Chemistry, Medicinal

Extremely Potent Block of Bacterial Voltage-Gated Sodium Channels by μ-Conotoxin PIIIA

Rocio K. Finol-Urdaneta, Jeffrey R. McArthur, Vyacheslav S. Korkosh, Sun Huang, Denis McMaster, Robert Glavica, Denis B. Tikhonov, Boris S. Zhorov, Robert J. French

MARINE DRUGS (2019)

Article Neurosciences

Ketamine inhibits synaptic transmission and nicotinic acetylcholine receptor-mediated responses in rat intracardiac ganglia in situ

Alexander A. Harper, Katrina Rimmer, Jhansi Dyavanapalli, Jeffrey R. McArthur, David J. Adams

NEUROPHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Structural basis of the potency and selectivity of Urotoxin, a potent Kv1 blocker from scorpion venom

Karen Luna-Ramirez, Agota Csoti, Jeffrey R. McArthur, Yanni K. Y. Chin, Raveendra Anangi, Rosby del Carmen Najera, Lourival D. Possani, Glenn F. King, Gyorgy Panyi, Haibo Yu, David J. Adams, Rocio K. Finol-Urdaneta

BIOCHEMICAL PHARMACOLOGY (2020)

Review Chemistry, Medicinal

Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds

Rocio K. Finol-Urdaneta, Aleksandra Belovanovic, Milica Micic-Vicovac, Gemma K. Kinsella, Jeffrey R. McArthur, Ahmed Al-Sabi

MARINE DRUGS (2020)

Article Neurosciences

Molecular and Functional Characterization of Neurogenin-2 Induced Human Sensory Neurons

Amy J. Hulme, Jeffrey R. McArthur, Simon Maksour, Sara Miellet, Lezanne Ooi, David J. Adams, Rocio K. Finol-Urdaneta, Mirella Dottori

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Article Pharmacology & Pharmacy

Spider Venom Peptide Pn3a Inhibition of Primary Afferent High Voltage-Activated Calcium Channels

Jeffrey R. McArthur, Nehan R. Munasinghe, Rocio K. Finol-Urdaneta, David J. Adams, Macdonald J. Christie

Summary: Research has shown that Pn3a produces analgesic effects by inhibiting HVA Ca(v), with enhanced inhibition observed when co-administered with opioid agonists.

FRONTIERS IN PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Small-molecule mimicry hunting strategy in the imperial cone snail, Conus imperialis

Joshua P. Torres, Zhenjian Lin, Maren Watkins, Paula Florez Salcedo, Robert P. Baskin, Shireen Elhabian, Helena Safavi-Hemami, Dylan Taylor, Jortan Tun, Gisela P. Concepcion, Noel Saguil, Angel A. Yanagihara, Yixin Fang, Jeffrey R. McArthur, Han-Shen Tae, Rocio K. Finol-Urdaneta, B. Duygu Ozpolat, Baldomero M. Olivera, Eric W. Schmidt

Summary: Venomous cone snails use small molecules in their venom to mimic natural mating pheromones of their prey polychaete worms, evoking mating behavior. These specialized metabolites are species-specific and structurally diverse, indicating that cone snails may adopt various prey-hunting strategies facilitated by small molecules. In the phenomenon of aggressive mimicry, C. imperialis uses metabolically stable mimics of prey pheromones, highlighting a unique aspect of biological mimicry in chemical ecology.

SCIENCE ADVANCES (2021)

Article Cell & Tissue Engineering

In vivo survival and differentiation of Friedreich ataxia iPSC-derived sensory neurons transplanted in the adult dorsal root ganglia

Serena Viventi, Stefano Frausin, Sara E. Howden, Shiang Y. Lim, Rocio K. Finol-Urdaneta, Jeffrey R. McArthur, Kwaku Dad Abu-Bonsrah, Wayne Ng, Jason Ivanusic, Lachlan Thompson, Mirella Dottori

Summary: Friedreich ataxia is characterized by degeneration of sensory neurons due to low Frataxin levels. Transplantation of stem cell-derived progenitors into DRG regions showed survival and differentiation, expressing neuronal markers. This study suggests the potential of using stem cells for cell replacement therapy in treating neurodegeneration in FRDA.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Pharmacology & Pharmacy

Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation

Clifford TeBay, Jeffrey R. McArthur, Melissa Mangala, Nicholas Kerr, Stewart Heitmann, Matthew D. Perry, Monique J. Windley, Jamie Vandenberg, Adam P. Hill

Summary: Hydroxychloroquine, chloroquine, and azithromycin have been proposed as drugs to treat COVID-19, but they carry a risk of proarrhythmia. Factors such as electrolyte imbalances, acidosis, and temperature can alter the potency of these drugs and increase the risk of proarrhythmia. In vitro screening and in silico simulations can help guide the preclinical screening and clinical management of patients receiving these drugs.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Multidisciplinary Sciences

Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider

Rocio K. Finol-Urdaneta, Rebekah Ziegman, Zoltan Dekan, Jeffrey R. McArthur, Stewart Heitmann, Karen Luna-Ramirez, Han-Shen Tae, Alexander Mueller, Hana Starobova, Yanni K. -Y. Chin, Joshua S. Wingerd, Eivind A. B. Undheim, Ben Cristofori-Armstrong, Adam P. Hill, Volker Herzig, Glenn F. King, Irina Vetter, Lachlan Rash, David J. Adams, Paul F. Alewood

Summary: The venom of the King Baboon spider contains a cysteine-rich peptide that can induce pain by targeting multiple ion channels, leading to hyperexcitability in pain-sensing neurons. This peptide may be an evolutionary adaptation for pain induction in defensive venoms.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Pharmacology & Pharmacy

Analgesic a-Conotoxin Binding Site on the Human GABAB ReceptorS

Anuja R. Bony, Jeffrey R. McArthur, Akari Komori, Ann R. Wong, Andrew Hung, David J. Adams

Summary: This study identifies the binding site of analgesic a-conotoxins on the human GABAB receptor and the key residues involved in the interaction. Furthermore, the study explores the sensitivity of other mutants to the analgesic a-conotoxins.

MOLECULAR PHARMACOLOGY (2022)

Article Biology

μ-Theraphotoxin Pn3a inhibition of CaV3.3 channels reveals a novel isoform-selective drug binding site

Jeffrey R. McArthur, Jierong Wen, Andrew Hung, Rocio K. Finol-Urdaneta, David J. Adams, Henry M. Colecraft

Summary: The spider venom peptide inhibitor Pn3a has been identified as a subtype-selective inhibitor of the Ca(V)3.3 T-type calcium channel. It modifies the gating of Ca(V)3.3 and decreases its currents by shifting the voltage dependence of activation. This study expands our understanding of T-type calcium channel pharmacology and highlights the potential use of Pn3a as a molecular tool in studying the physiological roles of Ca(V)3.3 channels.

ELIFE (2022)

Article Neurosciences

Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine

Neven Maksemous, Claire D. Blayney, Heidi G. Sutherland, Robert A. Smith, Rod A. Lea, Kim Ngan Tran, Omar Ibrahim, Jeffrey R. McArthur, Larisa M. Haupt, M. Zameel Cader, Rocio K. Finol-Urdaneta, David J. Adams, Lyn R. Griffiths

Summary: By analyzing whole-exome sequencing data, we found that rare variants in the CACNA1I gene may be associated with the occurrence of hemiplegic migraine.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)

Meeting Abstract Biophysics

Modulation of Native and Recombinant GIRK1/2 Channels by Analgesic α-conotoxins

Anuja R. Bony, Jeffrey R. McArthur, Rocio K. Finol-Urdaneta, David J. Adams

BIOPHYSICAL JOURNAL (2020)

No Data Available